Xencor's XmAb®5871 Program to be Featured in Poster Presentation at European League Against Rheumatism (EULAR) 2015 Annual Meeting Read more about Xencor's XmAb®5871 Program to be Featured in Poster Presentation at European League Against Rheumatism (EULAR) 2015 Annual Meeting
Xencor Reports First Quarter 2015 Financial and Operating Results Read more about Xencor Reports First Quarter 2015 Financial and Operating Results
Xencor to Webcast Presentations at Two Upcoming Conferences in May Read more about Xencor to Webcast Presentations at Two Upcoming Conferences in May
Xencor to Host First Quarter 2015 Financial Results Webcast and Conference Call on May 4, 2015 Read more about Xencor to Host First Quarter 2015 Financial Results Webcast and Conference Call on May 4, 2015
Xencor Appoints A. Bruce Montgomery, M.D. to Board of Directors Read more about Xencor Appoints A. Bruce Montgomery, M.D. to Board of Directors
Xencor to Present at 22nd Annual BioCentury Future Leaders in the Biotech Industry Conference Read more about Xencor to Present at 22nd Annual BioCentury Future Leaders in the Biotech Industry Conference
Xencor, Inc. Announces Completion of Public Offering of Common Stock and Exercise in Full of Option to Purchase Additional Shares of Common Stock Read more about Xencor, Inc. Announces Completion of Public Offering of Common Stock and Exercise in Full of Option to Purchase Additional Shares of Common Stock
Xencor, Inc. Prices Public Offering of Common Stock Read more about Xencor, Inc. Prices Public Offering of Common Stock
Xencor, Inc. Announces Proposed Public Offering of Common Stock Read more about Xencor, Inc. Announces Proposed Public Offering of Common Stock
Xencor Reports Fourth Quarter and Full Year 2014 Financial Results Read more about Xencor Reports Fourth Quarter and Full Year 2014 Financial Results